1977
DOI: 10.1677/joe.0.0740375
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Central Defeminization but Not Masculinization in Male Rats by Inhibition Neonatally of Oestrogen Biosynthesis

Abstract: An inhibitor of aromatization, androsta-1,4,6-triene-3,17-dione (ATD), was administered to newborn male and female rats and various parameters of gonadal and sexual function were examined in adulthood. Males injected with 1 mg ATD on the day of birth (day 1) and on days 3, 5, 10 and 15 postnatally, subsequently (day 55) showed normal male and female copulatory behaviour, but were not able to maintain cyclicity in ovarian transplants. When the ATD was administered by Silastic implants, however, cyclicity in ova… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
55
3
1

Year Published

1981
1981
2008
2008

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 146 publications
(60 citation statements)
references
References 19 publications
1
55
3
1
Order By: Relevance
“…That there is a difference in effect between rats and humans is hardly surprising, in view of the gross differences in behaviors observed, time courses of perinatal hormone administration and of developmental sequences, and the particular steroids administered. The relative vulnerability of masculine and feminine behavior patterns to neonatally administered progesterone in this study is, however, somewhat surprising in light of reports that neonatal treatment of intact males with an aromatase inhibitor (which blocks conversion of androgens to estrogens) enhanced the display of feminine behavior but did not affect masculine behavior of rats [5,23]. On the other hand, administration of an aromatase inhibitor together with testosterone to neonatally castrated rats suppressed both masculinization and defeminization [2].…”
Section: Discussioncontrasting
confidence: 66%
“…That there is a difference in effect between rats and humans is hardly surprising, in view of the gross differences in behaviors observed, time courses of perinatal hormone administration and of developmental sequences, and the particular steroids administered. The relative vulnerability of masculine and feminine behavior patterns to neonatally administered progesterone in this study is, however, somewhat surprising in light of reports that neonatal treatment of intact males with an aromatase inhibitor (which blocks conversion of androgens to estrogens) enhanced the display of feminine behavior but did not affect masculine behavior of rats [5,23]. On the other hand, administration of an aromatase inhibitor together with testosterone to neonatally castrated rats suppressed both masculinization and defeminization [2].…”
Section: Discussioncontrasting
confidence: 66%
“…Dihydrotestosterone (a non-aromatizable androgen) is unable to affect reproductive function (Whalen & Luttge 1971, McDonald & Doughty 1972, 1974, and the effects of testosterone were blocked by inhibitors of aromatization (Vreeburg et al 1977) and antioestrogens (McDonald & Doughty 1972). The analysis of the effects of combined administration of testosterone and oestradiol with raloxifene supports the oestrogenic activity of raloxifene.…”
Section: Discussionmentioning
confidence: 95%
“…For the rabbit, data represent means Ϯ SEM; for the ferret, individual profiles of LH release following mating in a representative male and female tested while in breeding condition. male rat's hypothalamus (161,220,226). However, the site and mechanism by which testosterone acts to masculinize the neuroendocrine circuitry controlling GnRH release in males is unclear.…”
Section: Figmentioning
confidence: 99%
“…BAKKER AND BAUM male rat's hypothalamus (161,220,226). However, the site and mechanism by which testosterone acts to masculinize the neuroendocrine circuitry controlling GnRH release in males is unclear.…”
mentioning
confidence: 99%